Rubin Jami 4
4 · Relay Therapeutics, Inc. · Filed May 27, 2022
Insider Transaction Report
Form 4
Rubin Jami
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-27+41,597→ 41,597 totalExercise: $17.33Exp: 2032-05-26→ Common Stock (41,597 underlying)
Footnotes (1)
- [F1]This option was granted on May 27, 2022 with respect to 41,597 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date.